(Q33842475)

29 July 2017

1 reference

title

Gastroesophageal reflux: practical management of a common, challenging disorder (English)

1 reference

29 July 2017

A H Soll

1

1 reference

29 July 2017

R Fass

series ordinal

2

1 reference

29 July 2017

publication date

1 January 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

1

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

1-17

1 reference

Typical and atypical presentations of gastroesophageal reflux disease. The role of esophageal testing in diagnosis and management

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2899%2990085-6

7 January 2021

Determinants of gastroesophageal junction incompetence: hiatal hernia, lower esophageal sphincter, or both?

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2899%2990085-6

7 January 2021

Cigarette smoking and gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2899%2990085-6

7 January 2021

Tolerance to oral H2-receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2899%2990085-6

7 January 2021

The effectiveness of ranitidine in reducing gastric acid-secretion decreases with continued therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2899%2990085-6

7 January 2021

Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2899%2990085-6

7 January 2021

Nocturnal intragastric acidity during and after a period of dosing with either ranitidine or omeprazole.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2899%2990085-6

7 January 2021

Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2899%2990085-6

7 January 2021

Marked increase in gastric acid secretory capacity after omeprazole treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2899%2990085-6

7 January 2021

The effect of decaffeination of coffee on gastro-oesophageal reflux in patients with reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2899%2990085-6

7 January 2021

Relaxation training reduces symptom reports and acid exposure in patients with gastroesophageal reflux disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2899%2990085-6

7 January 2021

10.1016/S1098-3597(99)90085-6

Identifiers

DOI

1 reference

29 July 2017

1 reference